Visit dentist before radiation therapy to prevent oral problems

December 10, 2003

More than one million Americans will be diagnosed with cancer each year, and about 40 percent will develop serious mouth problems as the result of head and neck radiation therapy and chemotherapy. Severe oral complications, such as the patient's inability to eat and drink, often force doctors to delay or stop the radiation treatment.

To give patients their best chance to fight cancer, the dentist must be added to the cancer treatment team and the patient must visit the dentist before beginning radiation therapy, according to a new report in the November/December 2003 issue of General Dentistry, the Academy of General Dentistry's (AGD) clinical, peer-reviewed journal.

The goal of head and neck radiation is to kill cancer cells while limiting damage to adjacent healthy tissue and structures like salivary glands, jawbones and tissues lining the mouth. However, damage to healthy tissue is unavoidable.

During treatment, the dentist can work with the patient to monitor any changes in their mouth that may occur, such as dry mouth, increased cavities and painful mouth sores.

"The less oral problems a patient experiences, the more likely the patient will stay on the treatment program," says Bruce Burton, DMD, MAGD, ABGD, AGD spokesperson.

"Schedule a visit with the dentist one month before starting radiation," advises Jody S. Harrison, DDS, lead report author. "Doing so may help prevent serious complications."

Oral complications from neck and head radiation

Pretreatment strategies for cancer patients

Academy of General Dentistry

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to